MECP2 and atypical Rett syndrome: Furthermore, the ability of decitabine to induce Mecp2e1/MeCP2E1 at both transcript and protein levels provide insights for future therapeutic strategies for MeCP2 deficiency-related neurodevelopmental disorders such as autism and Rett syndrome.